VAERS Explorer
Back to explore

Report #2847528

Received Jun 27, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
NC
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (2)

TypeNameManufacturerDoseLotRoute / Site
HPV9HPV (GARDASIL 9)MERCK & CO. INC.UNK——
HPV9HPV (GARDASIL 9)MERCK & CO. INC.UNK——

Symptoms (2)

Incomplete course of vaccinationNo adverse event

Symptom narrative

female patient last received 2 doses of GARDASIL-9 in 2021 but did not complete the series; No additional AE; This spontaneous report was received from a nurse referring to a 27-year-old female patient. No information regarding the patient's pertinent medical history, drug reactions or allergies, or concomitant therapies was provided. On an unknown date in 2021, she received the first and second dose of Human Papillomavirus 9-valent vaccine, recombinant suspension for injection for prophylaxis (dose, route of administration, vaccination scheme frequency, anatomical location, lot number, and expiration date were not reported), the reporter did not know why patient did not receive the 3rd dose (Inappropriate schedule of product administration). There was not adverse event reported (No adverse event).